Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Saudi Arabia · Delayed Price · Currency is SAR 222.60
+1.20 (0.54%)
Oct 15, 2026, 3:19 PM AST
TADAWUL:4013 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 77,910 | 89,950 | 98,140 | 99,400 | 77,210 | 56,490 | |
Market Cap Growth | -19.35% | -8.34% | -1.27% | 28.74% | 36.68% | 48.07% |
Enterprise Value | 85,840 | 97,423 | 103,456 | 102,180 | 78,536 | 57,003 |
Last Close Price | 222.60 | 253.02 | 271.29 | 270.43 | 206.76 | 148.97 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.20 | 37.46 | 42.39 | 48.58 | 46.77 | 41.04 |
Forward PE | 27.48 | 33.36 | 39.40 | 45.09 | 44.39 | 39.03 |
PS Ratio | 5.33 | 6.56 | 8.76 | 10.45 | 9.29 | 7.79 |
PB Ratio | 8.81 | 10.67 | 12.89 | 14.69 | 12.65 | 10.22 |
P/TBV Ratio | 9.43 | 11.38 | 13.68 | 15.33 | 13.13 | 10.58 |
P/FCF Ratio | 45.75 | 214.86 | - | - | 58.04 | 60.79 |
P/OCF Ratio | 19.29 | 26.44 | 33.04 | 30.64 | 27.15 | 25.88 |
PEG Ratio | 1.90 | 2.30 | 2.27 | 2.45 | 2.22 | 4.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.88 | 7.11 | 9.24 | 10.75 | 9.45 | 7.86 |
EV/EBITDA Ratio | 24.35 | 30.51 | 38.16 | 43.33 | 40.06 | 32.98 |
EV/EBIT Ratio | 31.40 | 37.20 | 43.91 | 48.76 | 46.18 | 38.88 |
EV/FCF Ratio | 50.41 | 232.71 | - | - | 59.04 | 61.34 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.09 | 1.10 | 1.07 | 0.77 | 0.58 | 0.55 |
Debt / EBITDA Ratio | 2.77 | 2.83 | 2.94 | 2.15 | 1.75 | 1.72 |
Debt / FCF Ratio | 5.68 | 22.23 | - | - | 2.65 | 3.29 |
Net Debt / Equity Ratio | 0.83 | 0.83 | 0.69 | 0.38 | 0.13 | 0.07 |
Net Debt / EBITDA Ratio | 2.16 | 2.20 | 1.95 | 1.09 | 0.40 | 0.24 |
Net Debt / FCF Ratio | 4.32 | 16.78 | -6.15 | -10.14 | 0.58 | 0.44 |
Asset Turnover | 0.62 | 0.63 | 0.62 | 0.67 | 0.71 | 0.71 |
Inventory Turnover | 8.76 | 10.15 | 10.75 | 12.10 | 12.43 | 12.54 |
Quick Ratio | 0.77 | 0.84 | 0.98 | 1.01 | 1.35 | 1.73 |
Current Ratio | 1.12 | 1.15 | 1.28 | 1.25 | 1.61 | 2.02 |
Return on Equity (ROE) | 30.08% | 31.07% | 32.96% | 32.65% | 29.04% | 26.14% |
Return on Assets (ROA) | 7.17% | 7.48% | 8.10% | 9.23% | 9.08% | 9.02% |
Return on Invested Capital (ROIC) | 16.70% | 18.28% | 20.83% | 25.04% | 24.94% | 23.94% |
Return on Capital Employed (ROCE) | 14.10% | 14.20% | 14.40% | 16.80% | 17.00% | 16.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.11% | 2.67% | 2.36% | 2.06% | 2.14% | 2.44% |
FCF Yield | 2.19% | 0.46% | -0.87% | -0.25% | 1.72% | 1.65% |
Dividend Yield | 2.17% | 1.88% | 1.70% | 1.52% | 1.58% | 1.74% |
Payout Ratio | 68.28% | 69.23% | 70.90% | 70.14% | 68.91% | 68.65% |
Total Shareholder Return | 2.17% | 1.88% | 1.70% | 1.52% | 1.58% | 1.74% |